Corbin Capital Partners’s Biotech Acquisition Company Class A Ordinary Shares BIOT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-928,124
| Closed | -$9.37M | – | 107 |
|
|
2022
Q4 | $9.37M | Hold |
928,124
| – | – | 2.85% | 10 |
|
|
2022
Q3 | $9.21M | Hold |
928,124
| – | – | 2.29% | 15 |
|
|
2022
Q2 | $9.19M | Hold |
928,124
| – | – | 2.08% | 18 |
|
|
2022
Q1 | $9.15M | Hold |
928,124
| – | – | 1.56% | 21 |
|
|
2021
Q4 | $9.13M | Hold |
928,124
| – | – | 1.57% | 21 |
|
|
2021
Q3 | $9.04M | Hold |
928,124
| – | – | 1.76% | 20 |
|
|
2021
Q2 | $8.98M | Hold |
928,124
| – | – | 1.86% | 21 |
|
|
2021
Q1 | $9.02M | Buy |
+928,124
| New | +$9.02M | 2.13% | 20 |
|